Rutin: A Novel A2AR Antagonist with Promising Therapeutic Potential for Cancer Immunotherapy | Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds | Alps Pharmaceutical Ind. Co.,Ltd.

Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

Rutin: A Novel A2AR Antagonist with Promising Therapeutic Potential for Cancer Immunotherapy

Authors:: Sarah Kandoussi; Soumaya Rafii; Yassine El Ghallab; Souha Sahraoui; Abdallah Badoua

Reference:: Journal of Bioinformatics and Systems Biology; 2025; 8; 51-57

DOI:: 10.26502/jbsb.5107104

See Abstract

Key Words:: Adenosine A2A receptor; molecular docking; rutin

Back to index